Work

Pre-treatment circulating tumor DNA as a biomarker for disease burden in diffuse large B cell lymphoma (DLBCL).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.8539

Authors: Florian Scherer, David Matthew Kurtz, Michael Richard Green, Aaron M. Newman, Daniel M. Klass, Li Zhou, Rashi Krishnan, Chih Long Liu, Cynthia Glover, Robert S. Ohgami, Rodney J Hicks, Colm Keane, Katherine A Kong, Malek Faham, Mark S. Hertzberg, Maher K Gandhi, Ranjana H. Advani, Ronald Levy, Maximilian Diehn, Ash A. Alizadeh

Institutions: Stanford Medicine, Stanford University, University of Nebraska Medical Center, Peter MacCallum Cancer Centre, Princess Alexandra Hospital, Westmead Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2516412776

Cites:

Cited by:

Related to: 10